Archive June

Archive for June, 2018

$TOPS Announces Time Charter With Oil Major For 2 Suezmax Vessels

ATHENS, Greece, June 07, 2018 — TOP Ships Inc. (the “Company”), an international owner and operator of modern, fuel efficient “ECO” tanker vessels focusing on the transportation of crude oil and petroleum products, announced today that it has agreed to enter into time charter employment with a major oil company for its two Suezmax vessels currently under construction at Hyundai Samho, South Korea, with Hull numbers S874 and S875 (the “Vessels”).

The Vessels will be employed for a firm period of 36 months plus two additional 12 month periods, at the charterer’s option, starting upon the Vessels’ deliveries expected to take place in April 2019 and May 2019. The revenue backlog expected to be generated by this fixture, assuming all options are exercised, is about $96 million.

The Company had previously entered into charter agreements with a related party for the Vessels. The related party consented to be replaced by the new charterer, which was secured by the company’s CEO.

Evangelos Pistiolis, the President, Chief Executive Officer and Director of the Company, said:

“We are very happy to have entered into this fixture for our very high specification scrubber fitted Suezmax vessels. Our strategy of acquiring very high quality tonnage has once again been embraced by top quality charterers. Due to their scrubbers, these vessels have achieved daily rates that are above the current market thereby giving us a payback on investment for scrubbers in less than 2 years. These charters will significantly facilitate the financing of the vessels due to the charter duration, the rate and the quality of the counterparty. Total gross revenue backlog for the fixed charter period of operating vessels as of June 7, 2018 is about $177 million, increasing to about $192 million when adding the 50% of our joint venture vessels.”

Following the abovementioned time charters, the Company’s projected charter coverage is as follows:

Year	Operating fleet	Operating fleet including vessels partly owned through joint ventures
2018	100%	100%
2019	83%	86%
2020	76%	80%
2021	36%	37%
2022	6%	5%

About TOP Ships Inc.

TOP Ships Inc. is an international ship-owning company.
For more information about TOP Ships Inc., visit its website: www.topships.org.

Forward-Looking Statements

Matters discussed in this press release may constitute forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides safe harbor protections for forward-looking statements in order to encourage companies to provide prospective information about their business. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements, which are other than statements of historical facts.

The Company desires to take advantage of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and is including this cautionary statement in connection with this safe harbor legislation. The words “believe,” “anticipate,” “intends,” “estimate,” “forecast,” “project,” “plan,” “potential,” “may,” “should,” “expect” “pending” and similar expressions identify forward-looking statements. The forward-looking statements in this press release are based upon various assumptions, many of which are based, in turn, upon further assumptions, including without limitation, our management’s examination of historical operating trends, data contained in our records and other data available from third parties. Although we believe that these assumptions were reasonable when made, because these assumptions are inherently subject to significant uncertainties and contingencies which are difficult or impossible to predict and are beyond our control, we cannot assure you that we will achieve or accomplish these expectations, beliefs or projections.

Contacts:
Mr. Craig Brelsford
REDCHIP
Tel: +1 407 571 0902
Email: Craig@redchip.com

Thursday, June 7th, 2018 Uncategorized Comments Off

$HMMR Employs Two-phase Strategy to Advance in the Telecommunications Market

Recognizing and addressing a need for change in the way television, internet and phone services are delivered
Two phases currently in the works to strategically launch the company
Building market visibility and greater brand awareness as a leader in unifying communications technologies

Hammer Fiber Optics Holdings Corp. (OTCQB: HMMR) is a telecommunications company investing in the future of wireless technology. Recognizing a need for change in the way television, internet and phone services are delivered, HMMR has aligned with companies who also recognize this need. Through diversified holdings, a broad outlook and varied partnerships, the company has created a unique opportunity in the telecommunications marketplace. HMMR offers innovative alternatives to markets where a single cable provider or satellite may be the only available option.

There are two phases to the company’s launch. Phase one relates to the recent launch in New Jersey. New Jersey is dense in population but considered a broadband desert. HMMR seeks to change the landscape of wireless technology in this area by providing residents and businesses a new alternative where fiber optics are not available. The company provides high-capacity broadband, voice and video through direct fiber, as well as its wireless fiber platform – Hammer Wireless® AIR technology.

Phase two will be to move the company nationally by strategically partnering with wireless internet service providers or small cable operators who already have wireless in place. “This is the most efficient use of spectrum that has ever been witnessed in a point to multi-point product,” President and CEO Mark Stogdill stated in reference to the patented AIR technology. “There is no product in the world today that can deliver this type of performance” (http://nnw.fm/c8zzY).

The company’s holdings include Hammer Fiber Optic Investments, Ltd. D/B/A Hammer Fiber, but the primary business of HMMR is the wholly owned subsidiary Hammer Communications, which is proving itself a leader in unifying the way that television, internet and phone services are delivered (www.HammerComm.com). In a strategic move to increase market visibility and drive greater brand awareness, HMMR has engaged the communication expertise of NetworkNewsWire (http://nnw.fm/W42jI).

For more information, visit the company’s website at www.HammerCorp.info

More from NetworkNewsWire

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Thursday, June 7th, 2018 Uncategorized Comments Off

$FRSX Close to Rolling Out Cutting-Edge Vision System for Driverless Cars

QuadSight™ multi-spectral automotive vision system detects close to 100 percent of obstacles
System uses four cameras to detect obstacles in all lighting and weather conditions
Foresight expects QuadSight™ to be commercialized next year
Insurance industry evidence shows that driver-assistance technology reduces vehicle crashes, injuries and deaths

With recent fatal accidents fresh in the public mind involving cars equipped with driver-assistance technology, Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) is pressing on with a unique obstacle-detection vision system that raises the safety standard higher than ever.

In an audio press release on May 24 (http://nnw.fm/A0nJi), Foresight said that its QuadSight™ system promises key advantages over other detection systems currently at various stages of development for use in self-driving cars. In tests, QuadSight’s™ sensors achieved close to 100 percent detection of obstacles. Foresight expects to commercialize the system next year.

QuadSight™ works by using input from four cameras, two of which function on the infrared spectrum and two in visible light. The images from the cameras are then interpreted by advanced vision-processing algorithms that have been successfully used all over the world for almost 20 years by Foresight’s main shareholder, homeland security technology firm Magna BSP Ltd. This combination of infrared and visible light spectrum input means that QuadSight™ detects obstacles whatever the weather and at any time of day or night.

Quoted in the press release, Foresight CEO Haim Siboni said, “Vision is the foundation of passenger safety, and vision perfection under all weather and lighting conditions is clearly the breakthrough that vehicle makers need to build consumer confidence in order to accelerate autonomous vehicle adoption.”

With industry specialists and legislators fully expecting self-drive cars to be part of the near future of motoring (http://nnw.fm/e0IMw), Foresight has been working since 2015 to develop vision sensor technologies that will work in a timely and accurate manner.

Besides QuadSight™, the Israel-based company has also developed Eyes-On™, an advanced driver assistance technology that, in addition to detecting hazards like pedestrians, animals and other vehicles, also warns motorists when they stray out of their lanes. Foresight is also behind Eye-Net™, a cellular-based app that alerts pedestrians and vehicles of collision dangers from road users outside their field of vision, such as objects approaching around the corner.

Driver-assisted technologies have proven to drastically reduce motor vehicle accidents, deaths and injuries. According to the Insurance Institute for Highway Safety website, crash avoidance features using some of the same sensing and control technologies that underpin automation are already proving effective. Features such as automatic braking, blind spot detection, lane departure warning and electronic stability control have shown potential to prevent crashes (http://nnw.fm/07cMN).

Early this year, a survey by the American Automobile Association (AAA) found that consumers are growing more positive toward driverless vehicles (http://nnw.fm/KT7Il). According to the AAA, this rising consumer confidence could be the result of drivers learning more about self-driving vehicle technology and themselves using driver assistance technology.

With QuadSight™, Eyes-On™ and Eye-Net™, Foresight is perfecting a highly promising line of automotive vision systems that will further increase the safety and dependability of driver assistance and automated vehicle technology, positioning the company for sustained growth as a worthwhile investment opportunity in this fast-growing market.

For more information, visit the company’s website at www.ForesightAuto.com

More from NetworkNewsWire

About NetworkNewsWire

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Thursday, June 7th, 2018 Uncategorized Comments Off

$ETST Shares Updates on its CBD Formula Patents and Medical Device

DORAL, Florida, June 07, 2018 — Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, as well as research and development, is pleased to share updates on its ongoing CBD formula patents and medical device progress.

In March 2018 the Company announced it had received a grant from the Government of Quebec to develop its three new cannabinoid-based products. The prototyping of the three CBD formula patents has begun at CDBQ. The first batch will be tested by the team, and in vitro testing will begin in summer 2019 to show the superior antioxidant activities and better anti-proliferative effects on breast cancer cells. The stability tests will be done over a 1-year period. The third product, which is a superfood edible, will be ready for Q4 of 2018. The branding of these unique products is currently in the planning stage. It is anticipated that these original products, made from high quality ingredients, will achieve great success since their function is to maintain quality of life, prevent inflammation, cancer and degenerative diseases.

Earth Science Tech also shares its progress in the launch of the MSN-2 medical device and finalization of the last step before large scale deployment. The company is working with Accélération, Design et Innovation Inc. (ADI Hardware Accelerator). The final packaging will have a great look that women – the target market – will appreciate. Our partners from Djibouti, Morocco, Vietnam, and the Middle East can’t wait to see and test our new medical device which is dedicated to improving the health of women in their countries and around the world.

The Company’s CEO and Chief Science Officer, Dr. Michel Aubé stated, “The official launch of this medical device is a little like giving birth. It will be unique in the marketplace and we are branding this device globally. The commercial name will be announced soon, as we are in the process of trademark protection for the logo and name. We will create a strong demand for this medical device by showing the world its powerful capacity to diminish the prevalence of chlamydia and other Sexually Transmitted Infections.”

About Earth Science Tech, Inc. (ETST)

Earth Science Tech, Inc. (“ETST”) offers the highest purity and quality high-grade full spectrum cannabinoid oil on the market. There are positive results in studies on breast cancer and immune cells through the University of Central Oklahoma, and studies through DV Biologics proved it lowers cortisol and functions as a neuro-protectant, with positive result case studies through key health organizations. ETST formulates, markets, and distributes the CBD oil used for its studies to the public, offering the most effective quality of CBD on the market.
To learn more, please visit: www.EarthScienceTech.com

ETST currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

Earth Science Pharmaceutical

Earth Science Pharmaceutical, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc (ETST). Earth Science Pharma, Inc. (“ESP”), which is committed to the development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. ESP’s CEO and chief science officer Dr. Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. ESP is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
To learn more please visit: www.EarthSciencePharmaceutical.com

Cannabis Therapeutics

Cannabis Therapeutics, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc. (ETST). Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds three provisional application patents for a CBD product that is focused on developing treatments for breast and ovarian cancers, as well as two generic CBD based pharmaceutical drugs.
To learn more please visit: www.CannabisThera.com

KannaBidioiD

KannaBidioid, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc. (ETST). KannaBidioiD, Inc. (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.
To learn more please visit: www.KannaBidioiDInc.com

Earth Science Foundation, Inc.

Earth Science Foundation, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc. (ETST). Earth Science Foundation, Inc. (“ESF”), is in the process of becoming a non-profit organization to accept grants and donations to conduct further studies and help donate Earth Science Tech, Inc’s effective CBD products to those in need.
To learn more please visit: www.ETSTFoundtion.org

SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations Contact:
Dave Demarest 
305.546.7640 Office

Company Contact:
www.EarthScienceTech.com  
Nickolas S. Tabraue
President & Director
305.615.2118

Thursday, June 7th, 2018 Uncategorized Comments Off

$ABCCF Announces Results of Annual General Meeting

NAPANEE, Ontario, June 07, 2018 — ABcann Global Corporation (TSX-V:ABCN) (“ABcann” or the “Company”) is pleased to announce the results of its annual general and special meeting of shareholders held on June 5, 2018 (the “Meeting”).

The Company put forward the following resolutions to be voted on by shareholders at the Meeting, all of which were approved: (i) to re-appoint MNP LLP, Chartered Accountants, as auditor of the Company for the 2018 fiscal year; (ii) fixing the number of directors of the Company at six; (iii) the election of directors; (iv) the ratification and approval of the Company’s 2017 Stock Option Plan; and (v) the approval of a future change of name of the Company, to be determined and made at the discretion of the Company’s board of directors (the “Board”).

A total of 46,801,699 of the 191,001,305 common shares of the Company that were outstanding as at the record date were voted at the Meeting, representing 24.5% of such shares.

Each of the directors elected at the Meeting, being Paul Lucas, Barry Fishman, John Easson, Richard Fitzgerald, Aaron Keay and Daryl Kramp, will hold office until the next annual meeting of the Company or until their earlier resignation or removal. Andrew LaCroix did not stand for re-election at the Meeting but will continue in his role with the Company as Vice-President, International Business and General Counsel.

Following the Meeting, the Board determined to grant an aggregate of 710,000 stock options to certain directors and employees of the Company, each of which is exercisable into one common share of the Company at an exercise price of $1.39 per share until June 5, 2023. Of these, an aggregate of 190,000 options were granted to certain directors of the Company, and an aggregate of 520,000 options were granted to certain employees of the Company or subsidiaries thereof. The options granted will vest in stages in accordance with their respective terms. The shares issuable on exercise of the stock options will be subject to a TSX Venture Exchange hold period of four months and one day from the date of grant of the options. The Board also approved the grant of 200,000 restricted share units to a director, each of which, once vested on June 5, 2019, may be redeemed into one common share.

About ABcann Global

ABcann Global Corporation is committed to becoming a top five cannabis company, recognized for high-quality, trusted and innovative products and services. ABcann holds production and sales licenses from Health Canada. Its flagship facility in Napanee, Ontario contains proprietary plant-growing technology, centred on its specially designed, environmentally-controlled growing chambers. This approach results in the production of pharmaceutical-grade cannabis products. ABcann is expanding its production capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, such as Germany, Australia and Israel.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For more information about ABcann, please contact:

Barry Fishman at barry.fishman@abcannglobal.com 
or Michael Bumby at michael.bumby@abcannglobal.com 
and visit abcannglobal.com.

Thursday, June 7th, 2018 Uncategorized Comments Off

$AXON Licenses Investigational Gene Therapy for Parkinson’s Disease

Exclusive worldwide license to lentiviral vector gene therapy constitutes the first transaction of Axovant’s 2018 pipeline expansion
Fraser Wright, Co-Founder and former Chief Technology Officer of Spark Therapeutics, to join Axovant as CTO for gene therapy programs
Axovant will receive $25 million equity financing from Roivant Sciences to support clinical development of AXO-Lenti-PD and additional business development
Conference call / webcast today at 8:00am Eastern Time

BASEL, Switzerland, June 06, 2018 (GLOBE NEWSWIRE) — Axovant Sciences (NASDAQ:AXON) today announced that it has licensed the exclusive worldwide rights to develop and commercialize OXB-102, now AXO-Lenti-PD, from Oxford BioMedica. AXO-Lenti-PD is an investigational gene therapy for Parkinson’s disease that delivers three genes encoding a critical set of enzymes required for dopamine synthesis in the brain. Oxford BioMedica is a world leader in lentiviral vector product development and manufacturing, and will be the clinical and commercial supplier of AXO-Lenti-PD. Axovant expects to initiate a Phase 1/2 dose escalation study of AXO-Lenti-PD in patients with advanced Parkinson’s disease by the end of 2018.

Under the terms of the license agreement with Oxford BioMedica, Axovant obtained rights to AXO-Lenti-PD, as well as its predecessor product ProSavin®, for an initial payment of $30 million in cash, $5 million of which will be applied as a credit against the process development work and clinical supply that Oxford BioMedica will provide to Axovant. Oxford BioMedica is also eligible to receive additional development, regulatory, and commercial milestone payments potentially in excess of $812 million, and tiered royalties on net sales of AXO-Lenti-PD, if approved. Roivant has agreed to purchase $25 million of Axovant common shares, which will support the clinical development of AXO-Lenti-PD and additional business development activities.

Fraser Wright, PhD, will join Axovant as Chief Technology Officer overseeing the company’s gene therapy initiatives. Dr. Wright is the Co-Founder and former Chief Technology Officer of Spark Therapeutics and has over 20 years of leadership experience in the development of novel vector-based biologic products. At Spark he oversaw process development and clinical-stage manufacturing for LUXTURNA™. Prior to Spark, he was the founding Scientific Director of the Clinical Vector Core Laboratory at The Children’s Hospital of Philadelphia, where he directed clinical core staff in gene therapy investigational product development, manufacture, and quality control testing for ten first-in-human viral vector investigational products including LUXTURNA™ and Kymriah®. He was also previously the Director of Development and Clinical Manufacturing at Avigen. Dr. Wright was formerly a Research Professor of Pathology and Laboratory Medicine at the University of Pennsylvania School of Medicine, and he is the lead inventor on numerous issued patents during his time in that role. He received his BSc and PhD in biochemistry from the University of Toronto, where he was also an assistant professor of biochemistry and medicine.

Pavan Cheruvu, MD, Chief Executive Officer of Axovant, stated: “Axovant remains committed to developing innovative treatments for serious neurodegenerative conditions such as Parkinson’s disease, and we are excited to partner with Oxford BioMedica, a recognized global leader in cell and gene therapy. We are also pleased to welcome Fraser to our leadership team. He brings over two decades of experience in gene therapy manufacturing, and will be committed to building world-class gene therapy capabilities at Axovant. We will continue to pursue promising new therapeutic approaches based on transformative science, and will further expand our pipeline with high-quality assets like AXO-Lenti-PD. This is part of our long-term goal of building Axovant into a leader in the development and commercialization of innovative new medicines for neurological indications.”

“This is an exciting time to join Axovant, and I look forward to the opportunity to work closely with Oxford BioMedica and help build gene therapy capabilities at Axovant,” said Dr. Wright. “AXO-Lenti-PD is a strong foundation for Axovant’s new pipeline, and I am excited to begin preparing the Phase 1/2 clinical study in advanced Parkinson’s disease later this year.”

Commenting on the announcement, John Dawson, Chief Executive Officer of Oxford BioMedica said: “We are delighted to sign this significant agreement which not only underlines our LentiVector®-enabled platform and product development strategy but further demonstrates Oxford BioMedica’s ability to build multiple partnerships with leaders in their respective therapeutics fields. We believe Axovant’s expertise and focus on neurological disorders, which includes Parkinson’s disease, makes them an ideal development and commercialisation partner for this programme. Coupled with strong support and financial resources from parent company Roivant, we believe Axovant is well positioned to advance the development of AXO-Lenti-PD for the treatment of patients with Parkinson’s, a disease which still has a high unmet need.”

Teleconference/Webcast Details

To participate in the live conference call today, June 6, at 8:00 a.m. EDT, please dial 1-833-652-5918 from the U.S. and Canada or +1 409-767-9227 internationally, and use the passcode 8289429.

The live call is being webcast and can be accessed on the “Events and Presentations” page of the “Investors” section of the Company’s website at http://investors.axovant.com. A replay of the webcast will be available for 30 days following the live event.

About AXO-Lenti-PD

AXO-Lenti-PD, formerly OXB-102, is an investigational gene therapy for Parkinson’s disease that delivers three genes encoding a critical set of enzymes required for dopamine synthesis in the brain and is designed to provide patient benefit for multiple years following a single administration. AXO-Lenti-PD is a next-generation gene therapy with a modified payload configuration of the predecessor product, ProSavin®, to further improve endogenous dopamine production. Oxford BioMedica has successfully completed a Phase 1/2 study for ProSavin®, which met its primary endpoint. The results, which were published in The Lancet in 2014, demonstrate favorable safety and tolerability and a statistically significant improvement of motor function as measured by the UPDRS Part III score at 6 and 12 months. This improvement was sustained in most patients for up to four years despite the progressively degenerative nature of Parkinson’s disease.

About Parkinson’s Disease

Parkinson’s disease is caused by degeneration of nerve cells in a portion of the brain called the substantia nigra which leads to a reduction in dopamine. Low dopamine causes nerve cells to activate without normal control. Characteristic Parkinson’s disease symptoms include tremor, limb rigidity, slow physical movement, and gait and balance issues. Approximately one million Americans live with Parkinson’s disease, with 60,000 diagnosed each year. The combined direct and indirect cost of Parkinson’s disease, including treatment, Social Security payments, and lost income, is estimated to be nearly $25 billion per year in the United States alone.

About Axovant Sciences

Axovant is a clinical-stage biopharmaceutical company dedicated to advancing innovative treatments for patients with serious neurologic and neuropsychiatric conditions, and turning promising therapies into lasting solutions for patients. Axovant is committed to developing and commercializing a pipeline of product candidates by identifying and developing novel treatments for unmet needs in neurology and psychiatry.

About Oxford BioMedica

Oxford BioMedica (LSE:OXB) is a leading gene and cell therapy group focused on developing life changing treatments for serious diseases. Oxford BioMedica and its subsidiaries (the “Group”) have built a sector-leading lentiviral vector delivery platform (LentiVector®), which the Group leverages to develop in vivo and ex vivo products both in-house and with partners. The Group has created a valuable proprietary portfolio of gene and cell therapy product candidates in the areas of oncology, ophthalmology and CNS disorders. The Group has also entered into a number of partnerships, including with Novartis to manufacture Kymriah®, Bioverativ, Sanofi, GSK, Orchard Therapeutics, GC LabCell and Immune Design, through which it has long-term economic interests in other potential gene and cell therapy products. Oxford BioMedica is based across several locations in Oxfordshire, UK and employs more than 320 people.

About Roivant Sciences

Roivant Sciences is a global biopharmaceutical company focused on reducing the time and cost of the drug development process to improve the lives of patients and their families. Roivant partners with innovative biopharmaceutical companies and academic institutions to ensure that important medicines are rapidly delivered to patients.

Forward-Looking Statements and Information

This press release contains forward-looking statements, including statements regarding Axovant’s plans to advance the development of AXO-Lenti-PD and expand its pipeline. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially and reported results should not be considered as an indication of future performance. These risks and uncertainties include, but are not limited to: risks associated with the ability to identify and in-license or acquire product candidates, and the success, cost, and timing of Axovant’s product development activities and any planned clinical trials. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to Axovant’s business in general, see the “Risk Factors” section of Axovant’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (SEC) on February 9, 2018, and other filings that Axovant makes with the SEC from time to time. These forward-looking statements are based on information available to Axovant as of the date of this press release and speak only as of the date of this release. Axovant disclaims any obligation to update these forward-looking statements, except as may be required by law.

Financial details regarding this transaction will be provided in Axovant’s Form 8-K to be filed with the SEC. All trademarks are property of their respective owners.

Contacts:

Investors

Tricia Truehart
(631) 892-7014
investors@axovant.com

Media

Paul Davis
(646) 495-5310
media@axovant.com

Wednesday, June 6th, 2018 Uncategorized Comments Off

$VSQTF Incorporates Blockchain Technology into Various Markets

NetworkNewsWire Editorial Coverage: The freelance employment market now comprises 34 percent of the United States workforce, according to a recent report, with freelance workers contributing approximately $1.4 trillion to the nation’s economy (http://nnw.fm/ZLkg1). Intrinsically connected with today’s freelance market, digital services has a compound annual growth rate of 6 percent and may be poised to become one of the next global economic drivers. Blockchain is a revolutionary technology that has the potential to fuel the growth of the digital freelance services market by enabling secure, transparent and rapid transactions. Companies bringing “Blockchain” to new industries include Bitcoin Investment Trust (OTC: GBTC), MGT Capital Investments, Inc. (OTCQB: MGTI), HIVE Blockchain Technologies Ltd. (OTC: HVBTF) (TSX-V: HIVE), Global Blockchain Technologies Corp. (OTC: BLKCF) (CSE: BLOC) and Victory Square Technologies, Inc. (OTC: VSQTF) (CSE: VST) (VSQTF Profile).

Forbes reported that the next great area of blockchain disruption in 2018 could be the online freelancing business (http://nnw.fm/iJ6DM). Blockchain startups that spot this potentially profitable market gap are already popping up on the digital map. Capaciti, the professional services marketplace of parent company Howyl Ventures — which was recently acquired in part by Victory Square Technologies (OTC: VSQTF) (CSE: VST) — is poised to potentially be a big disruptor in the digital freelance space (http://nnw.fm/92N0u).

Targeting launch in Q3 of this year, Capaciti will be the world’s first blockchain-based, enterprise-grade marketplace for digital design and technology development services. With platform transactions projected to reach $36.9 million in 2019 and to surge to over $495 million by 2022, Capaciti looks like it is setting the stage for a billion-dollar show.

Capaciti’s application of blockchain technology upgrades an online marketplace from a manual, analog process to a decentralized, automated marketplace. This innovation could create the foundation for the next evolution of connecting talent and clients in the digital marketplace.

The market for Victory Square Technologies’ Capaciti’s initial service offering is substantial. In the United States alone, the software development market is estimated at over $235 billion per year, with 70 percent of that spend flowing to outsourced partners or freelance professionals.

The world’s workforce has become decentralized, and digital services business connections are now mostly made in online marketplaces. Freelancing is predicted to become the workforce majority within a decade (http://nnw.fm/zVJ6d). Upwork, arguably the world’s largest and most successful online marketplace for freelance services, generates $1.5 billion per year in revenues and is targeting $10 billion in annual revenue by 2022. 99Designs reports a design upload occurs every second, and designers have made over $200 million on the site from over 444,000 clients.

Capaciti’s incubator, Victory Square Technologies, has a management team of established leaders in blockchain technology and digital marketplaces. The company was named one of the top 14 blockchain companies to watch in 2018 by Entrepreneur.com (http://nnw.fm/9xCil). CEO Shafin Diamond Tejani was named Canadian Angel Investor of the Year in 2017. Tejani has also launched more than 40 startups and has generated over $100 million in revenues per year.

Capaciti co-founders Marc Low, Steve Davis and Gary Bode have a successful track record of delivering projects using a distributed workforce model for big brands such as HCL Technology, Barclays Bank, Sotheby’s, Pacific Union International and Estee Lauder. They have collectively launched the global talent crowdsourcing platform Deloitte Pixel, held a senior marketing role at Apple and grown the team at Chimp Technology from five people to more than 70.

Victory Square Technologies’ Capaciti could potentially disrupt this trillion-dollar market that is in serious need of a technology upgrade.

Major Money Markets Ripe for Disruption

Capaciti’s freelance software development platform alone breaks into a $237 billion market. With plans to expand into additional service verticals, Victory Square Technologies new acquisition may have spotted a massive untapped reservoir of enterprise-grade business. Marketplaces such as Upwork, 99designs and Fiverr service some of the need but remain challenged in areas that can create a price squeeze in a hypercompetitive environment. Price squeezes can drive down profit margins to unsustainable levels for vendors.

Small-business clients often mine these sites to find workers for the lowest possible rate. Business relationships in online project marketplaces can start off well but end badly, with losses being cut on both sides. Workers pressure clients into payment for incomplete or insufficient work or want to move off the contracting platform to communicate and transact.

These markets, then, are arguably ripe for disruption.

Decluttering and De-risking the Online Marketplace

Victory Square Technologies’ Capaciti’s model pairs top-tier enterprise clients with top-tier talent to effectively deliver projects, creating an exchange that removes many risk elements.

Capaciti’s business model moderates business relationships in the online marketplace. Rather than just creating a job board on which to post and pitch, participants on the platform vet the profiles and reputations of both freelancers and clients. Capaciti solves the mystery of who the clients and vendors are and what they do best. The company has designed a system for executing enterprise-level projects in a way that avoids the pitfalls of overpricing and delivery disagreements.

A blockchain-based reputation management protocol empowers vendors to earn a transparent and auditable “reputation score.” Blockchain smart contracts are used to manage contractual obligations between client and vendor and increase the speed and efficiency with which freelancers get paid for work performed, as payment settlements are transferred instantly upon successful completion.

With blockchain technology, a global reach and a laser focus on user retention, Victory Square Technologies’ Capaciti could potentially upstage companies such as Upwork, 99designs and Fiverr.

A Tech Vertical Fueled for Hypergrowth

The Capaciti platform is already being used internally by Victory Square Technologies to service existing client work and, once launched publicly, could be well-positioned to scale rapidly. First launching in the North American market, Capaciti will begin expansion into key markets in Europe and Asia next year. Victory Square Technologies’ investment in Capaciti sets the stage for success for this technology-driven vertical, already poised for growth and slated to launch soon with transactions projected in the millions straight out of the gate.

Potential Comparables:

Bitcoin Investment Trust (OTC: GBTC) is a traditional investment vehicle with shares titled in the investors’ names, providing a familiar structure for financial and tax advisors and easy transferability to beneficiaries under estate laws. Shares of the Bitcoin Investment Trust are eligible to be held in certain IRA, Roth IRA, and other brokerage and investor accounts.

MGT Capital Investments, Inc. (OTC: MGTI) is based in Durham, North Carolina, and ranks as one of the largest United States-based bitcoin miners. The company also has expanded facilities in Washington State and in Sweden.

HIVE Blockchain Technologies Ltd. (OTC: HVBTF) (TSX-V: HIVE) is building a bridge from the blockchain sector to traditional capital markets. HIVE is strategically partnered with Genesis Mining Ltd., the world’s leading cryptocurrency mining hashrate provider, to build the next generation of blockchain infrastructure. HIVE also owns a state-of-the-art GPU-based cryptocurrency mining facility in Iceland.

Global Blockchain Technologies Corp. (OTC: BLKCF) (CSE: BLOC) provides investors access to a mixture of assets in the blockchain space, strategically chosen to balance stability and growth. Blue chip holdings such as Ethereum and Bitcoin are complemented by best-of-breed “smaller cap” crypto holdings, many of which are not yet available to other investors.

Big Opportunities in Online Project Network

The over-trillion-dollar digital services market is clearly on an upward trajectory, and the online project-based network represents an opportunity for blockchain incubators such as Victory Square Technologies.

For more information on Victory Square Technologies Inc. (OTC:VSQTF) (CSE:VST), please visit StreetSignals.com for the FULL report.

About NetworkNewsWire

For more information, please visit https://www.NetworkNewsWire.com

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

DISCLAIMER: NetworkNewsWire (NNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by NNW are solely those of NNW. Readers of this Article and content agree that they cannot and will not seek to hold liable NNW for any investment decisions by their readers or subscribers. NNW is a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, NNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

NNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and NNW undertakes no obligation to update such statements.

Wednesday, June 6th, 2018 Uncategorized Comments Off

$CIIX Enters Into a Licensing Partnership With The Bad Crypto Podcast

NEW YORK, June 5, 2018 —

ChineseInvestors.com, Inc. (OTCQB: CIIX) (“CIIX” or the “Company”), the premier financial information website for Chinese-speaking investors, today announced that it has entered into a licensing partnership with The Bad Crypto Podcast to re-distribute the podcast’s most popular interviews on http://www.newcoins168.com , in Chinese.

Interviews that will be translated into Chinese for re-distribution on http://www.newcoins168.com include: Charlie Lee, Founder and Developer of Litecoin, Roger Ver, also known as ‘Bitcoin Jesus’, and Patrick Bryne, Overstock.com CEO and Founder of tZERO. In addition to re-distributing these informative interviews in Chinese, the Company’s CEO Warren Wang also appeared once again for an interview on The Bad Crypto Podcast on May 23, 2018. Mr. Wang first appeared on The Bad Crypto Podcast in December 2017 where he offered his perspective and insights on bitcoin and cryptocurrency in China.

“Since it first aired in July 2017, The Bad Crypto Podcast hosted by Joel Comm, Bitcoin Evangelist and Travis Wright, Blockchain Entrepreneur, has become a worldwide phenomenon with over 150 episodes for curious individuals trying to figure out cryptocurrency, blockchain and the future of digital payments,” says ChineseInvestors.com, Inc. CEO Warren Wang. “We are confident that this lighthearted, entertaining programming offered in Chinese will be well received by viewers looking to expand their crypto knowledge whether they are newbies or more experienced crypto investors.”

About ChineseInvestors.com (OTCQB: CIIX)

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis, and educational related services in Chinese language character sets (traditional and simplified); (b) advertising and public relation related support services; and (c) retail, online and direct sales of hemp-based products and other health related products.

For more information visit ChineseInvestors.com

Subscribe and watch our video commentaries: https://www.youtube.com/user/Chinesefncom

Like us on Facebook to receive live feeds: https://www.facebook.com/Chinesefncom;

https://www.facebook.com/Chineseinvestors.com.english

Add us on WeChat: Chinesefn or download iPhone iOS App: Chinesefn.

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.

Contact:
ChineseInvestors.com, Inc.
227 W. Valley Blvd, #208 A
San Gabriel, CA 91776

Investor Relations:
Alan Klitenic
+1-214-636-2548

Corporate Communications:
NetworkNewsWire (NNW)
New York, New York
http://www.NetworkNewsWire.com
+1-212-418-1217 Office
Editor@NetworkNewsWire.com

Tuesday, June 5th, 2018 Uncategorized Comments Off

$NETE Free Research Report from WallStEquities

LONDON, UK / June 5, 2018 / If you want a free Stock Review on SNAP sign up now at www.wallstequities.com/registration. On Monday, June 04, 2018, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged higher at the closing bell. Seven out of nine sectors ended Monday’s trading session in bullish territories. Taking into consideration yesterday’s market sentiment, WallStEquities.com assessed the following Internet Software & Services equities this morning: Net Element Inc. (NASDAQ: NETE), SINA Corp. (NASDAQ: SINA), Snap Inc. (NYSE: SNAP), and Square Inc. (NYSE: SQ). All you have to do is sign up today for this free limited time offer by clicking the link below.

www.wallstequities.com/registration

Net Element

On Monday, shares in North Miami Beach, Florida headquartered Net Element Inc. recorded a trading volume of 164,354 shares. The stock ended at $6.85, declining 2.84% from the last trading session. The Company’s shares have gained 29.98% over the previous three months. The stock is trading below its 50-day moving average by 13.19%. Furthermore, shares of Net Element, which operates as a financial technology and value-added solutions company worldwide, have a Relative Strength Index (RSI) of 35.66. Get the full research report on NETE for free by clicking below at:

www.wallstequities.com/registration/?symbol=NETE

SINA Corp.

Beijing, China headquartered SINA Corp.’s stock finished yesterday’s session 1.18% higher at $93.33. A total volume of 943,949 shares was traded. The Company’s shares have gained 4.81% in the last twelve months. The stock is trading below its 50-day moving average by 2.41%. Furthermore, shares of SINA, which through its subsidiaries, operates as an online media company in China, have an RSI of 52.06. Today’s complimentary research report on SINA is accessible at:

www.wallstequities.com/registration/?symbol=SINA

Snap Inc.

At the close of trading on Monday, shares in Venice, California headquartered Snap Inc. saw a rise of 5.93%, ending the day at $12.32. The stock recorded a trading volume of 50.56 million shares, which was higher than its three months average volume of 25.15 million shares. The Company’s shares have advanced 12.31% in the last month. The stock is trading below its 50-day moving average by 6.43%. Moreover, shares of Snap, which operates as a camera company in the US and internationally, have an RSI of 60.41.

On May 21st, 2018, research firm MoffettNathanson upgraded the Company’s stock rating from ‘Sell’ to ‘Neutral’. Sign up for free on Wall St. Equities and claim the latest report on SNAP at:

www.wallstequities.com/registration/?symbol=SNAP

Square

San Francisco, California headquartered Square Inc.’s shares ended the day 3.01% higher at $61.62 with a total trading volume of 10.70 million shares. The stock has gained 24.36% in the last month, 21.38% in the previous three months, and 163.79% over the last twelve months. The Company’s shares are trading above their 50-day and 200-day moving averages by 19.32% and 48.94%, respectively. Additionally, shares of Square, which provides payment and point-of-sale solutions in the US and internationally, have an RSI of 74.62.

On June 01st, 2018, research firm Needham reiterated its ‘Buy’ rating on the Company’s stock with an increase of the target price from $55 a share to $65 a share. See the free research coverage on SQ at:

www.wallstequities.com/registration/?symbol=SQ

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com
Phone number: 21 32 044 483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

Tuesday, June 5th, 2018 Uncategorized Comments Off

$ETST Attends Biggest, Sponsors 3 Cannabis Expos in Canada

DORAL, Florida, June 05, 2018 — Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, as well as research and development, offers a report on the company’s presence at four recent cannabis expos held in Canada and the United States. Over the past three weeks, Earth Science Tech attended the Toronto Lift & Co. Expo, sponsored and attended the CannXperience and Florida Medical Cannabis Conference & Exhibition, and sponsored the Cannabis World Congress & Business Expo.

Industry Day and Expo at the Lift and Co. Expo
The two Lift and Co. Expos in Toronto and Vancouver are the premier events for anyone involved in the Canadian cannabis industry, making it a perfect place for the ETST team to appear. Dr. Michel Aubé , the Company’s CEO & CSO, attended the event, networking with key individuals.

“I met many leaders in the Canadian medical cannabis industry, as well as future leaders in the burgeoning legal recreational cannabis industry and visionary lenders who are active in financing cannabis industry growth,” Aubé said. “We will pursue some of these new relationships in the coming months.”

CannXperience and Florida Medical Cannabis Conference & Exhibition
Both CannXperience and Florida Medical Cannabis Conference – held in Fort Lauderdale and Sarasota – involved Florida’s medical cannabis industry. ETST’ss COO Gagan Hunter attended both events, handing out samples and marketing material at a company-sponsored booth while representing the brand in his 15-minute speech presentation. The Company also helped sponsor the event, providing the ETST logo and Company information with event marketing material distributed throughout the event.

“Both events were very effective in spreading brand awareness, learning more about the industry, and networking,” Hunter said. “I got a lot of positive feedback on our brand and connected with many doctors, potential investors, and potential synergistic companies.”

Cannabis World Congress & Business Expo
The Cannabis World Congress & Business Expo in New York is a national level cannabis event which the Company sponsored to spread brand awareness.. The Company’s President and Director, Nickolas S. Tabraue, attended the event, learning from other companies and networking with individuals.

“Thanks to our passionate and like-minded team, we are now able to participate in beneficial cannabis industry events to spread awareness and network,” Tabraue said.. “A lot was achieved by sponsoring and attending the four events during the past three weeks, leaving a strong footprint in the cannabis industry. We look forward on attending more events to come and sharing many exciting updates very soon.”

About Earth Science Tech, Inc. (ETST)
Earth Science Tech, Inc. (“ETST”) offers the highest purity and quality high-grade full spectrum cannabinoid oil on the market. There are positive results in studies on breast cancer and immune cells through the University of Central Oklahoma, and studies through DV Biologics prove it lowers cortisol and functions as a neuro-protectant, with positive result case studies through key health organizations. ETST formulates, markets, and distributes the CBD oil used for its studies to the public, offering the most effective quality of CBD on the market.
To learn more, please visit: www.EarthScienceTech.com

Earth Science Pharmaceutical
Earth Science Pharmaceutical, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc (ETST). Earth Science Pharma, Inc. (“ESP”) is committed to the development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. ESP’s CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. ESP is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
To learn more please visit: www.EarthSciencePharmaceutical.com

Cannabis Therapeutics
Cannabis Therapeutics, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc. (ETST). Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds three provisional application patents for a CBD product that is focused on developing treatments for breast and ovarian cancers, as well as two generic CBD based pharmaceutical drugs.
To learn more please visit: www.CannabisThera.com

KannaBidioiD
KannaBidioid, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc. (ETST). KannaBidioiD, Inc. (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.
To learn more please visit: www.KannaBidioiDInc.com

Earth Science Foundation, Inc.
Earth Science Foundation, Inc., is awholly owned subsidiary of Earth Science Tech, Inc. (ETST). Earth Science Foundation, Inc. (“ESF”) is in the process of becoming a non-profit organization to accept grants and donations to conduct further studies and help donate Earth Science Tech, Inc.’s effective CBD products to those in need.
To learn more please visit: www.ETSTFoundtion.org

Investor Relations Contact:
Dave Demarest 
305.546.7640 Office

Company Contact:
www.EarthScienceTech.com  
Nickolas S. Tabraue
President & Director
305.615.2118

Tuesday, June 5th, 2018 Uncategorized Comments Off

$NETE JGR Capital Highlights Growth in Q1 2018, Events Industry Traction

Independent research firm JGR Capital predicts more growth for Net Element in North American and emerging markets
Research note also highlights company’s focus on the development of blockchain-based technology
Via Unified Payments subsidiary, vendors at any event will be able to use mobile point-of-sale tools and self-order kiosks to accept multi-channel payments

Global financial technology and value-added solutions group Net Element, Inc. (NASDAQ: NETE) is set for sustained organic growth through its North American transaction solutions segment. Following the release of its first quarter 2018 financial results, which included a 17.8 percent year-over-year revenue increase, independent equity research firm JGR Capital issued an updated research note on May 21 (http://nnw.fm/xh27A). The note mentioned Net Element’s Q1 2018 financial results, which indicated total revenue of $15.98 million, compared to $13.6 million in Q1 2017. It also remarked on how the same first quarter financials show that Net Element managed to cut its selling, general and administrative expenses by over $380,000.

Additionally, the research note made mention of the company’s expansion into international markets, with JGR Capital’s analysts expecting the Russian market to add to Net Element’s international revenues this year. The report attributed Net Element’s strong growth in North America to the success of its Aptito system, a payment service developed for the restaurant sector. Aptito’s cloud-based payment solution allows restaurants to integrate a point of sale solution with digital menus, self-order kiosks and kitchen displays.

Another major point noted by JGR Capital was the company’s focus on the development of blockchain-based technology with the launch of its proprietary Netevia platform, which offers same-day funding to eligible merchants, easy merchant account set up and integration, payment conversion optimization, competitive pricing for payment acceptance services and other advantages and features.

The JGR Capital update came two days before Net Element announced the launch of a payment solution tailor-made for the needs of the multibillion-dollar events industry (http://nnw.fm/O1X2f). Via subsidiary Unified Payments, events industry vendors will be able to use mobile point-of-sale systems and self-order kiosks, as well as benefit from chargeback protection and acceptance of multi-channel payments. Unified Payments’ solutions will be fully integrated with vendors’ existing payment systems, allowing seamless transactions

In a news release, Vlad Sadovskiy, Net Element’s president of integrated payments, said, “We are excited to provide the event management industry with fully integrated, feature rich payment acceptance solutions. Our capabilities have the potential to dramatically change the way event transactions are processed today.”

Vendors will have access to programs such as ‘Fast Pass Funding’, which allows same-day funding; ‘Complimentary Equipment Placement Program’, which offers access to free payments equipment rental and on-site tech support; and ‘Zero Pay’, a cash discount program which will allow vendors to pocket 100 percent of their sales revenue.

The move will allow Net Element to tap into a highly prolific market, which generates more than $330 billion in direct spending and over $845 billion in business sales each year while supporting 5.9 million jobs across the United States (http://nnw.fm/S0cM9).

For more information, visit the company’s website at www.NetElement.com

More from NetworkNewsWire

About NetworkNewsWire

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Monday, June 4th, 2018 Uncategorized Comments Off

$FRSX Completes Successful Trial of Cellular-Based Eye-Net™

The trial examined integration and interfacing of Foresight’s cellular-based accident prevention solution with smart infrastructure in the city of Ashdod.

Foresight Autonomous Holdings Ltd. (NASDAQ and TASE: FRSX), an innovator in automotive vision systems and V2X (vehicle to everything) cellular-based solutions, announced today, in collaboration with the city of Ashdod and NoTraffic Ltd., that is has successfully completed a controlled trial of its Eye-Net™ accident prevention solution. Eye-Net™ is a V2X cellular-based accident prevention solution, designed to provide pre-collision alerts in real time to pedestrians and vehicles by using smartphones and relying on existing cellular networks.

The trial was conducted at a central intersection in Ashdod, a city in the center of Israel, and was carried out in collaboration with NoTraffic Ltd., which develops traffic management systems for cities based on a network of sensors deployed at intersections with traffic lights. Supervision was provided by BWR (Blue and White Robotics) as part of the Ashdod Smart Mobility Living Lab project, and the trial was carried out with the support of the Ministry of Transport and the Ayalon Highway company as part of the national plan to promote smart transportation. The purpose of the trial was to integrate innovative technologies designed for smart cities, while creating a reliable communication channel between road users and smart infrastructure. During the trial, Foresight tested its Eye-Net™ system in various scenarios and integrated it with the NoTraffic smart system installed at the intersection.

In the first part of the trial, several accident-simulated scenarios including vehicles and/or a pedestrian were performed. In all cases, the parties were using the Eye-Net™ application installed on their cellular phones and received real-time alerts in order to prevent a collision. The second part of the trial tested the integration of the Eye-Net™ system with NoTraffic’s smart infrastructure system in accident-simulated scenarios where only one of the vehicles involved was connected to the Eye-Net™ system. NoTraffic’s system, which was installed at the intersection, identified the non-connected driver or pedestrian using a smart sensor, and transmitted the information to the driver using the Eye-Net™ system, in order to prevent a collision.

In all scenarios, Foresight met all the pre-defined objectives and indicators for the real-time use of the Eye-Net™ system in a manner that enabled all road users to brake safely and on time. During the trial, the information was streamed in real time to the control center onsite and displayed the location and time of occurrence of the simulated collisions on a map, as well as the classification of the road users involved.

“We were pleased to have the opportunity to introduce our company’s innovative system and collaborate with NoTraffic and the Ashdod Municipality, which, like Foresight, are entities that promote innovation and the use of advanced technologies in the field of accident prevention,” said Haim Siboni, CEO of Foresight. “This collaboration enabled us to test our ability to integrate with smart infrastructure in order to reduce the number of accidents in an urban environment. Integration with the NoTraffic system enabled Foresight to examine a variety of realistic scenarios, all of which presented impressive results. We intend to continue the development process in order to achieve extensive exposure for our company’s unique, life-saving technology.”

“The city of Ashdod, led by Dr. Yechiel Lasry, continues to promote the concept of smart transportation in order to improve the safety of the city’s residents,” said Dr. Smadar Itzkovich, Head of Industrial Development & Ashdod Smart Mobility Living Lab. “The trial was first of its kind and demonstrated how ‘smart’ communication between vehicles, pedestrians and traffic lights can identify and alert all road users of an upcoming collision. The trial results proved that the number of accidents can be significantly reduced. This is another step for the Ashdod Smart Mobility Living Lab in promoting smart transportation at the national and international levels.”

“We are glad to have the privilege to cooperate with Foresight and the Ashdod Municipality – two entities that are making every effort to promote smart transportation in Israel and abroad,” said Tal Kreisler, CEO of NoTraffic. “The trial was a breakthrough in the field of smart transportation and presents, for the first time, collaboration between infrastructure and road users in order to make the world a safer place where accidents are not commonplace. This is a significant milestone that sets the basis for preparing the roads for a connected and autonomous world by using advanced technology that can be deployed today. The scenarios demonstrated in the trial are based on recent fatal accidents of connected and autonomous vehicles that could be avoided in the future using the unique technology developed by NoTraffic.”

Foresight recently announced that it signed an agreement with Tamda Ltd. (TASE: TMDA) in order to merge its Eye-Net™-related activities into Tamda.

For more information about Foresight and its wholly owned subsidiary, Foresight Automotive, please visit www.foresightauto.com, follow @ForesightAuto on Twitter, or join Foresight Automotive on LinkedIn.

About Foresight

Foresight Autonomous Holdings Ltd. (NASDAQ and TASE: FRSX), founded in 2015, is a technology company engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry. Foresight’s vision systems are based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company, through its wholly owned subsidiary Foresight Automotive Ltd., develops advanced systems for accident prevention which are designed to provide real-time information about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts. The company’s systems are targeting the Advanced Driver Assistance Systems (ADAS), semi-autonomous and autonomous vehicle markets. The company estimates that its systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform and advanced technology.

About Ashdod Municipality and Ashdod Smart Mobility Living Lab Project

In recent years, the city of Ashdod has been promoting the Ashdod Smart Mobility Living Lab, in cooperation with MIT, which focuses on the use of urban space for the implementation of advanced technologies for smart and autonomous transportation. The purpose of the project is primarily to increase road safety and to encourage the use of public and cooperative transportation. In addition, a technological and legal infrastructure was established to promote cooperation with academic institutions and technological companies such as Mobileye, Microsoft, ITURAN, etc.

About NoTraffic

NoTraffic Ltd. develops a traffic management platform that optimizes traffic lights in real-time based on smart sensors, and prepares the road infrastructure for the connected and autonomous era. The platform is powered by integrating data from proprietary computer vision algorithms and data collected through vehicle-to-infrastructure (V2I) communication

Advanced artificial intelligence (AI) algorithms identify and track all road users, including pedestrians, and optimize the traffic signals while considering nearby intersection traffic. The system enables cities to implement their traffic policy in a seamless way and operates autonomously in order to maximize traffic flow, reduce congestion, prioritize different types of vehicles, and prevent accidents. www.notraffic.tech

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. For example, Foresight is using forward-looking statements in this press release when it discusses that it intends to continue the development process in order to achieve extensive exposure for the company’s unique, life-saving technology, and the closing of the merger agreement with Tamda, if at all. Because such statements deal with future events and are based on Foresight’s current expectations, they are subject to various risks and uncertainties and actual results, performance or achievements of Foresight could differ materially from those described in or implied by the statements in this press release.

The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed under the heading “Risk Factors” in Foresight’s annual report on Form 20-F filed with the Securities and Exchange Commission (“SEC”) on March 27, 2018, and in any subsequent filings with the SEC. Except as otherwise required by law, Foresight undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Foresight is not responsible for the contents of third party websites.

Investor Relations:
MS-IR
Miri Segal-Scharia, 917-607-8654
msegal@ms-ir.com
or
Corporate Communications:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212-418-1217 Office
Editor@NetworkNewsWire.com

Monday, June 4th, 2018 Uncategorized Comments Off

$DJACF Highlighted in BLOCKStrain Technology $DNAX Article on Big Data and Cannabis

Blockchain-based genetic registration process provides verification security for growers and consumers alike
Global cannabis market projected to reach $31.4 billion by 2021
WeedMD becomes first Canadian Licensed Producer to adopt BLOCKStrain’s technology

As the legal cannabis market continues to develop, concerns about ensuring transparency and quality control for the growing number of medicinal and recreational drug products sold to consumers continue to drive a necessary breed of entrepreneurship required to legitimize the industry. BLOCKStrain Technology Corp. (TSX.V: DNAX) has emerged as an innovative leader in the quality control arena, releasing its proprietary supply chain management platform as a secure means of providing confidence in the inventory pipeline while safeguarding the interests of licensed growers.

Blockchain’s ability to provide an inalterable and transparent multi-user platform for tracing manufacture-to-market transactions within virtually any industry has gained an exuberant following among investors during recent months, sparking sometimes-explosive growth in entities’ values.

BLOCKStrain has adapted the open-source ledger’s technology to provide a cannabis genome-to-sale genetic chain of evidence that provides proof of ownership to brand builders in the multibillion-dollar industry and allows consumers to verify where a product originated and where it has been before landing in their shopping carts. In between the two extremes of the pipeline, distributors, shipping companies and government agencies also have a stake in auditing a product’s wellbeing. Moreover, the platform forms the foundation for what could become IP protection for growers and producers who produce branded products.

WeedMD Inc. (TSX.V: WMD) (OTC: WDDMF) (FSE: 4WE), which recently announced a merger with Hiku Brands Co. Ltd. (CSE: HIKU) (OTC: DJACF), in May became the first Canadian Licensed Producer (LP) to adopt the BLOCKStrain platform for gene record-keeping purposes. As Canada and select U.S. states continue pushing toward full national legalization of cannabis as a recreational drug as well as a medicinal product, the BLOCKStrain platform ensures competitive advantage for their products at retail by giving consumers more transparent data on each product.

“Unique and differentiated strains and product offerings have always been, and will remain, a cornerstone of WeedMD’s business model. Validating and protecting that intellectual property through BLOCKStrain’s platform will prove invaluable as we scale operations and broaden our distribution throughout the country as well as internationally,” WeedMD Chief Financial Officer Keith Merker said about the agreement (http://cnw.fm/VAxF4).

Cannabis presents an interesting challenge to players in the industry. Increasingly in demand for its reputed healing properties as well as for a burgeoning social drug movement, the plant contains more than 500 known chemical compounds that are, in some cases, pharmacologically active and the basis of worldwide marijuana restrictions. With cannabis, consumers have a keen interest in being able to identify what they are purchasing at a genetic level, and blockchain provides the potential to build up a new breed of custom retail.

Government agencies also have a public stake in ensuring the production quality, product potency and measurable equivalency standards of cannabis derivatives claiming a medicinal or wellness benefit. BLOCKStrain helps provide the supply chain data to support a regulatory framework that achieves this goal.

Thousands of cannabis strains exist, and, as new breeding takes place, craft growers also have an interest in protecting their intellectual property. For growers, the BLOCKStrain platform provides a gene-registration defense of intellectual property rights and establishes a historical proof of ownership standard that may sustain challenges in the legal arena (http://cnw.fm/P9pGw). Once growers create an account with BLOCKStrain, they can deliver seeds, flower and derivative products that will be tested at an approved facility to provide identifying data. BLOCKStrain administrators also provide a verification process for pre-existing cannabis strain genetic data that can become part of a client’s profile.

Closing the consumer supply loop, users can also use BLOCKStrain to rate products and share their opinions, which become part of the strain’s immutable record.

“We have a mission to take an industry that was originated in the shadows and, using the power of big data and a blockchain-supported supply chain management model, bring it into the light,” stated BLOCKStrain CEO Robert Galarza. “The business opportunity is massive.”

For more information, visit the company’s website at www.BLOCKStrain.io

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Monday, June 4th, 2018 Uncategorized Comments Off

$DNAX Leverages #BigData to Secure #Cannabis Pipeline

Blockchain-based genetic registration process provides verification security for growers and consumers alike
Global cannabis market projected to reach $31.4 billion by 2021
WeedMD becomes first Canadian Licensed Producer to adopt BLOCKStrain’s technology

Closing the consumer supply loop, users can also use BLOCKStrain to rate products and share their opinions, which become part of the strain’s immutable record.

For more information, visit the company’s website at www.BLOCKStrain.io

More from CannabisNewsWire

About CannabisNewsWire

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Monday, June 4th, 2018 Uncategorized Comments Off

$PBIO Boosts Drug Development Process through Acquisition of PreEMT Platform

Biologics offer novel ways of treating degenerative diseases like Alzheimer’s
Biologics are one of the fastest-growing drug categories
PreEMT™ technology improves quality, reduces cost of biologic manufacture

When we think of drugs, an image of potions in round-bottom flasks conjured up in labs comes to mind, or perhaps pills of one sort or another ingested with a sip of water, for about 90 percent of drugs currently in use have that profile. However, discovering that the human body will act as its own physician by dispensing protective proteins called antibodies to fight the toxins that bring on diseases has spurred efforts, naturally enough, to develop those proteins synthetically. This new class of biotherapeutic protein drugs, or biologics, tends to be more effective at combating pathological conditions with less side effects, since they mimic endogenously produced proteins, which target highly specific parts of the invader (antigens). Unfortunately, the production of biologics is easier said than done; it typically requires hundreds of process steps to assemble one of these complex biotherapeutic proteins. Therefore, it should come as no surprise that the PreEMT™ platform recently acquired by Pressure BioSciences Inc. (OTCQB: PBIO) is a welcome addition to biologic development.

The company recently announced the signing of an agreement with an international biopharmaceutical company to assess the potential of the PreEMT™ technology as the basis for a unique manufacturing process and as an enhancement to the quality of a key protein-based drug currently under development (http://nnw.fm/Yr5lG).

Many currently available drugs are synthesized chemically, with molecular structures that are “well defined and relatively simple” (http://nnw.fm/abUv6). Their simplicity makes them easy to produce and easy for the human body to assimilate. A good example is acetylsalicylic acid (ASA), the active ingredient in aspirin, which has a molecular weight of about 180 grams per mole. Generally, such drugs are swallowed in pill or liquid form before entering the gastrointestinal system and blood stream by diffusion through the intestinal wall. Once in the blood, they have access to the entire body, their tiny size allowing them to penetrate cell membranes easily.

Biologics, by contrast, are much larger compounds that mimic the complex endogenous proteins produced by the immune system. They are generally composed of hundreds of amino acids and may carry a weight as high as 150,000 grams per mole. Biologics will bind to the specific cell receptors associated with a particular disease. For example, monoclonal antibodies are adept at recognizing very specific structures on the surface of cells. This specificity means that healthy cells are not adversely affected, resulting in less side effects. This is one reason that treatment by biologics can be superior to regimens developed with traditional combinatorial chemistries.

Because of their complexity, the manufacture of biotherapeutic proteins is prone to errors, very often falling prey to aggregation and misfolding. Misfolding occurs when the normal, three-dimensional structure of a protein becomes distorted, which may lead the protein to aggregate, a result that is quite the opposite of the benign outcomes intended in the manufacture of biologics. Many pathological conditions occur naturally by misfolded proteins. The list includes Alzheimer’s disease, which affects about 10 percent of the adult population over 65 years old in North America, as well as Parkinson’s disease and Huntington’s disease. However, PBIO’s PreEMT patented technology could reduce the incidence of misfolding in manufacture.

“PreEMT results in the dissolution of protein aggregates, which may have a significant impact on the quality of protein drugs by improving protein activity, homogeneity, and stability, as well as by reducing undesirable immunogenic properties”, Dr. Alexander Lazarev, PBIO’s vice president of R&D, stated in a news release.

Richard T. Schumacher, president and CEO of PBIO, added “Importantly, should the PreEMT technology result in more efficient production of high quality protein-based therapeutics for any biopharmaceutical company developing new protein-based therapeutics, manufacturing-scale licenses have the potential to generate millions of dollars in annual royalty revenue for PBIO.”

The technology is likely to find application across a wide range of proteins in reducing aggregation levels in bulk or final formulations, thereby improving product safety. PreEMT is scalable, and it is expected to significantly reduce manufacturing costs.

The acquisition of the PreEMT technology gives PBIO a footprint in the very large and growing biologics contract research services sector. The company is also busily developing its recently patented Ultra Shear Technology (UST) platform. The scalable, pressure-based UST technology creates stable nanoemulsions of otherwise immiscible fluids. It can be used to extend the shelf life of homogenized dairy products without refrigeration, for example. All the while, PBIO continues its focus on its core product line that generated $2.2 million in 2017 revenue: the development of pressure cycling technology (PCT)-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics and counter-bioterror applications.

For more information, visit the company’s website at www.PressureBioSciences.com

More from NetworkNewsWire

About NetworkNewsWire

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Friday, June 1st, 2018 Uncategorized Comments Off

$CIIX Focuses on Financial Consulting

Focusing on the initial vision of financial consulting to the Chinese-speaking community
Recent developments in CIIX’s cryptocurrency media and educational services, cryptocurrency ATMs and cryptocurrency mining shared at MicroCap Conference
Committed to continued real-time education regarding use of cryptocurrency

ChineseInvestors.com, Inc. (OTCQB: CIIX) provides real-time market commentary, analysis and education-related services to the Chinese-speaking community. “The company endeavors to be on the cutting edge of blockchain technology and to stay ahead of the curve in an effort to continue to build shareholder value and increase revenues this year,” CEO Warren Wang stated in a news release (http://cnw.fm/J0kLL). As the company spins off its hemp assets into a private company, it is refocusing on its initial vision of financial consulting. The company seeks to explore new ways of expansion within its core financial services. This move allows CIIX to focus on brand building, financial marketing and a recent move into the cryptocurrency and blockchain technology industry.

This past week, Wang presented at the MicroCap Conference in New York City. Micro- and small-cap attendees were presented information into CIIX’s developments in cryptocurrency business. Recent developments within the company were shared, including its developing cryptocurrency business focusing on cryptocurrency media and educational services, cryptocurrency ATMs and cryptocurrency mining.

The focus on educating CIIX’s global Chinese-speaking audience is evident on its crypto news website, www.NewCoins168.com, and through its daily video broadcast, ‘Bitcoin MultiMillionaire’, reporting on cryptocurrency news from the floor of the NYSE. These platforms only strengthen the company’s focus on being a leader in financial information. The company continues to be on the cutting edge of technology, with the use of a Bitcoin ATM in the lobby of its San Gabriel, California, headquarters providing instruction in both Chinese and English.

CIIX is also investigating ventures into cryptocurrency mining following its recent purchase of application specific integrated circuit (“ASIC”) machines that mine for cryptocurrencies, such as bitcoin and Litecoin. Initial reports suggest this will be a successful venture, and CIIX is considering the purchase of 500 or more additional ASIC units plus other equipment for blockchain mining.

For more information, visit the company’s website at www.ChineseInvestors.com

More from CannabisNewsWire

About CannabisNewsWire

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Friday, June 1st, 2018 Uncategorized Comments Off

$TMSR Common Stock Continues to Trade Following Nasdaq Hearings Panel Decision

TMSR Holding Company Ltd. (NASDAQ: TMSR), together with its subsidiaries, is a recognized leader in the research, development, production and sale of solid waste recycling systems and zero emissions process systems, for the industrial and mining sectors in the People’s Republic of China. The company operates through its wholly owned business divisions: Shengrong Environmental and Wuhan HOST Coating Materials.

TMSR’s Shengrong subsidiary designs, builds, sells and services customized solid waste recycling systems and equipment for some of the largest industries in China. The company provides customers full-service, tailor-made systems from conceptual design to planning, production, modernization, optimization, assembly, start-up, conversions, disassembly, maintenance and servicing of components to complete zero emissions solid waste recycling and process systems.

Utilizing what management believed to be the world’s most advanced technologies of physical magnetic industrial solid waste recovery, Shengrong can process a variety of industrial solid waste materials and is able to extract valuable metal byproducts from the waste without generating any chemical pollution. Shengrong’s patented equipment can process aluminum slag, copper mine tailings, iron mine tailings, red mud manganese tailings, and molybdenum tailings among many others. Unlike traditional chemical-based recovery methods, the company extracts resalable metals from the waste without generating any pollution. The residues are processed to manufacture high-quality construction materials, turning polluted solid waste into valuable industrial materials with zero discharge.

Industrial solid waste recycling and heavy metal removal are significant worldwide technical, financial and environmental issues. Through Shengrong, TMSR is addressing this profound unmet market need by delivering end users a clean alternative to traditional waste disposal. The company intends to leverage these serious unmet needs, expand its patented industrial waste recycling systems to broad international markets, and provide global industrial and mining businesses cost-effective, patented green technology platforms that create new-found revenue streams for end users.

Through Shengrong, TMSR owns two U.S. patents and five patents granted by the Peoples Republic of China, including four invention patents and two utility model patents. The company’s research and development efforts have achieved technological advancements that allow end users to eliminate pollutant discharge as well as generate new revenue streams by selling valuable byproducts extracted from industrial waste.

TMSR subsidiary, Wuhan HOST Coating Materials, is the largest manufacturer of inorganic Zinc-rich resin and one-component epoxy Zinc-rich resin in China. Established in 2010, Wuhan HOST is a leader in the research and development, production and sale of Zinc-rich coating materials throughout the PRC and has a broad customer base that includes some of the foremost enterprises in major industries such as electricity, metallurgy, machinery, chemicals, bridge and shipping. TMSR completed the acquisition of 100% equity interest in Wuhan HOST Coating Materials on May 1, 2018.

Notably, TMSR first went public as JM Global Holding Company, a Special Purpose Acquisition Company (SPAC) formed to effect a merger, asset acquisition or other business combination that had exceptional growth potential. After reviewing over 50 potential targets and completing due diligence and third party analysis, JM Global identified China Sunlong Environmental Technology Inc. and its wholly owned subsidiaries as the acquisition target. Upon closing the business combination, the company was re-named TMSR Holding Company Ltd.

Demand for TMSR’s products is expected to grow significantly due to Chinese policies that encourage mining and manufacturing companies to adopt “green” technology. Approximately 3 billion tons of industrial solid waste were generated annually in China between 2011 through 2015. Currently, 95% of industrial solid waste in China is stored in special facilities and sites; however, the cost of storage, disposal and incineration of industrial solid wastes is high. TMSR is focused on exploiting this unmet need, providing end users in the solid waste recycling markets a clean alternative to traditional waste disposal, significantly reducing solid waste discharge into the environment and enabling end users to extract value from industrial waste materials.

Friday, June 1st, 2018 Uncategorized Comments Off

$NETE Enables Sales Transactions through Broad Range of Platforms

Retail e-commerce sales expected to reach $4.88 trillion by 2021
Net Element enables expanding scope of face-to-face and e-commerce transactions
Company building additional transaction capabilities through blockchain project

In a world with rapidly expanding opportunities for commerce at a truly worldwide scale, one of the greatest challenges businesses face is staying abreast of the technologies that keep people linked together across the globe. Net Element, Inc. (NASDAQ: NETE) is in the business of making business happen, ensuring that sales transactions can take place across a wide array of potential platforms, globally or in-person right at a merchant’s store.

Not so far from the historical era of bartering for goods and services and yet light years ahead in terms of mobility, modern businesses and consumers are increasingly accustomed to moving merchandise without a ‘show-me-the-money’ mentality. Payment cards, emailed and texted statements and short-range electronic broadcasting all serve to verify in a confident and practically instantaneous manner that a resource of funds sufficient to cover a debt exists somewhere in the world and can be made available to another specified location somewhere in the world.

Through its brands, Net Element specializes in linking consumer mobile phones, banks, unbanked online distribution outlets and offline brick-and-mortar storefronts, providing value-added services and business analytics. The goal is to help companies assess their competition, evaluate their own productivity and get to know their clients’ preferences in the U.S. and emerging markets around the globe.

The company’s North America Transactions Solutions business segment recorded year-over-year revenue growth of 21 percent in 2017 with a history of 28 percent growth, driven mostly by its successes with its Unified Payments subsidiary (http://nnw.fm/zV1H8). Unified Payments’ Fast Pass Funding service gives eligible merchants access to revenues in as little as three hours during regular business days, improving turnaround time for transaction processing to same-day significance.

Entry into the Enterprise Ethereum Alliance has bolstered the company’s development of secure blockchain protocols to enhance its transaction solutions, including its new Netevia multi-channel payments platform that offers end-to-end processing through easy-to-use APIs. The company’s other subsidiaries — international small content mobile solution entity Digital Provider, cloud-based point-of-sale wireless tech platform Aptito, and processor agnostic e-commerce manager PayOnline — enhance its gravitas in the industry.

Independent equity research firm JGR Capital announced in April that it had launched its small cap data coverage of Net Element as a service to investors and shareholders (http://nnw.fm/M2ieN), providing additional attention to the company’s capabilities. In January, Net Element wrapped up a $7.55 million restricted common stock and warrant private placement with an institutional investor than brought in additional funding for its blockchain initiatives.

“The Company’s balance sheet is now the strongest in its history, allowing Net Element to support future growth opportunities,” Net Element CEO Oleg Firer stated in a news release.

Cumulative data from market analyst Statista projects that retail e-commerce sales worldwide will continue to grow at a marked pace, doubling revenues to $4.88 trillion by 2021. The analysis reports that online shopping is one of the most popular online activities worldwide, but the usage varies by region. In 2016, an estimated 19 percent of all retail sales in China occurred via internet, but, in Japan, the share was only 6.7 percent. Desktop PCs are still the most popular device for placing online shopping orders, but mobile devices, especially smartphones, are catching up, the report states (http://nnw.fm/sy5E3).

For more information, visit the company’s website at www.NetElement.com

More from NetworkNewsWire

About NetworkNewsWire

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Friday, June 1st, 2018 Uncategorized Comments Off

Archive for June, 2018

$TOPS Announces Time Charter With Oil Major For 2 Suezmax Vessels

$HMMR Employs Two-phase Strategy to Advance in the Telecommunications Market

$FRSX Close to Rolling Out Cutting-Edge Vision System for Driverless Cars

$ETST Shares Updates on its CBD Formula Patents and Medical Device

$ABCCF Announces Results of Annual General Meeting

$AXON Licenses Investigational Gene Therapy for Parkinson’s Disease

$VSQTF Incorporates Blockchain Technology into Various Markets

$CIIX Enters Into a Licensing Partnership With The Bad Crypto Podcast

$NETE Free Research Report from WallStEquities

$ETST Attends Biggest, Sponsors 3 Cannabis Expos in Canada

$NETE JGR Capital Highlights Growth in Q1 2018, Events Industry Traction

$FRSX Completes Successful Trial of Cellular-Based Eye-Net™

$DJACF Highlighted in BLOCKStrain Technology $DNAX Article on Big Data and Cannabis

$DNAX Leverages #BigData to Secure #Cannabis Pipeline

$PBIO Boosts Drug Development Process through Acquisition of PreEMT Platform

$CIIX Focuses on Financial Consulting

$TMSR Common Stock Continues to Trade Following Nasdaq Hearings Panel Decision

$NETE Enables Sales Transactions through Broad Range of Platforms

TraderPower Featured Companies

Top Small Cap Market News

Recent Posts

Recent Comments

Archives

Categories

Meta